Orgenesis Inc. (ORGS)
NASDAQ: ORGS · Real-Time Price · USD
0.618
+0.013 (2.22%)
At close: Sep 11, 2024, 4:00 PM
0.600
-0.018 (-2.90%)
After-hours: Sep 11, 2024, 4:19 PM EDT
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $29.00 million as of September 11, 2024. Its market cap has increased by 147.87% in one year.
Market Cap
29.00M
Enterprise Value
41.65M
1-Year Change
147.87%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since March 13, 2012, Orgenesis's market cap has decreased from $70.70M to $29.00M, a decrease of -58.98%. That is a compound annual growth rate of -6.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2024 | 28.40M | 77.50% |
| Dec 29, 2023 | 16.00M | -67.87% |
| Dec 30, 2022 | 49.80M | -28.76% |
| Dec 31, 2021 | 69.90M | -35.69% |
| Dec 31, 2020 | 108.70M | 44.36% |
| Dec 31, 2019 | 75.30M | 3.29% |
| Dec 31, 2018 | 72.90M | 24.62% |
| Dec 29, 2017 | 58.50M | 65.25% |
| Dec 30, 2016 | 35.40M | 12.74% |
| Dec 31, 2015 | 31.40M | -1.88% |
| Dec 31, 2014 | 32.00M | -2.14% |
| Dec 31, 2013 | 32.70M | 21.11% |
| Dec 31, 2012 | 27.00M | -61.81% |
| Mar 13, 2012 | 70.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 30.45M |
| Longeveron | 29.87M |
| ImmuCell | 29.69M |
| Streamline Health Solutions | 29.22M |
| Chemomab Therapeutics | 29.15M |
| Lumos Pharma | 28.92M |
| Movano | 28.79M |
| Achilles Therapeutics | 28.77M |